| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 10 | 2023 | 158 | 3.560 |
Why?
|
| Aerospace Medicine | 4 | 2022 | 51 | 1.070 |
Why?
|
| Human Experimentation | 1 | 2023 | 51 | 0.920 |
Why?
|
| Research Subjects | 1 | 2023 | 65 | 0.900 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 15 | 0.870 |
Why?
|
| Radiation Exposure | 1 | 2022 | 73 | 0.800 |
Why?
|
| Head-Down Tilt | 5 | 2018 | 24 | 0.780 |
Why?
|
| Radiation Protection | 1 | 2022 | 205 | 0.780 |
Why?
|
| Intracranial Pressure | 4 | 2018 | 180 | 0.720 |
Why?
|
| Psychiatry | 1 | 2023 | 307 | 0.690 |
Why?
|
| Weightlessness | 3 | 2018 | 72 | 0.670 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 119 | 0.640 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 93 | 0.590 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 111 | 0.530 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2015 | 32 | 0.530 |
Why?
|
| Astronauts | 4 | 2021 | 60 | 0.490 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 205 | 0.480 |
Why?
|
| Membrane Proteins | 12 | 2006 | 2819 | 0.470 |
Why?
|
| Carbon Dioxide | 4 | 2018 | 313 | 0.450 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 500 | 0.390 |
Why?
|
| Brain | 5 | 2023 | 4113 | 0.370 |
Why?
|
| Proteins | 4 | 2001 | 1963 | 0.300 |
Why?
|
| Receptors, Cell Surface | 4 | 2002 | 862 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 471 | 0.240 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 502 | 0.230 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2020 | 21 | 0.230 |
Why?
|
| Moon | 1 | 2022 | 14 | 0.220 |
Why?
|
| Mars | 1 | 2021 | 5 | 0.200 |
Why?
|
| Unemployment | 1 | 2020 | 31 | 0.190 |
Why?
|
| Proteinuria | 1 | 2001 | 155 | 0.190 |
Why?
|
| Mental Health | 1 | 2023 | 415 | 0.180 |
Why?
|
| Research Personnel | 1 | 2020 | 156 | 0.170 |
Why?
|
| Fetal Proteins | 1 | 1998 | 28 | 0.170 |
Why?
|
| Body Patterning | 1 | 1999 | 212 | 0.170 |
Why?
|
| Endopeptidases | 5 | 2005 | 220 | 0.170 |
Why?
|
| Intraocular Pressure | 2 | 2017 | 146 | 0.170 |
Why?
|
| Presenilin-2 | 9 | 2006 | 20 | 0.160 |
Why?
|
| Helminth Proteins | 1 | 1998 | 107 | 0.160 |
Why?
|
| Pupil | 1 | 2018 | 54 | 0.160 |
Why?
|
| Jugular Veins | 1 | 2018 | 107 | 0.160 |
Why?
|
| Blood Volume | 1 | 2018 | 100 | 0.150 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1998 | 129 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1999 | 272 | 0.150 |
Why?
|
| Megakaryocytes | 1 | 1997 | 104 | 0.150 |
Why?
|
| Hypercapnia | 1 | 2017 | 26 | 0.150 |
Why?
|
| Rest | 1 | 2017 | 71 | 0.150 |
Why?
|
| Radiation-Protective Agents | 1 | 2017 | 128 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.140 |
Why?
|
| Caenorhabditis elegans | 1 | 1998 | 268 | 0.140 |
Why?
|
| Presenilin-1 | 8 | 2005 | 71 | 0.140 |
Why?
|
| Urology | 1 | 2017 | 128 | 0.140 |
Why?
|
| Spinal Puncture | 1 | 2015 | 63 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 1997 | 345 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2022 | 2218 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 1997 | 560 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 190 | 0.120 |
Why?
|
| Reference Standards | 1 | 2015 | 339 | 0.120 |
Why?
|
| Microbiota | 1 | 2021 | 547 | 0.120 |
Why?
|
| Aspartic Acid Endopeptidases | 5 | 2005 | 44 | 0.120 |
Why?
|
| Weightlessness Simulation | 3 | 2018 | 24 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2002 | 5270 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 860 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2020 | 806 | 0.110 |
Why?
|
| Mice | 17 | 2008 | 34495 | 0.110 |
Why?
|
| Animals | 19 | 2022 | 59536 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 1183 | 0.110 |
Why?
|
| Kidney | 1 | 2001 | 2146 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 1498 | 0.110 |
Why?
|
| Humans | 21 | 2023 | 261506 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2001 | 1491 | 0.100 |
Why?
|
| Cross-Over Studies | 3 | 2017 | 460 | 0.100 |
Why?
|
| Cognition | 1 | 2017 | 968 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 590 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 830 | 0.100 |
Why?
|
| Health Behavior | 1 | 2014 | 603 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 1756 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2017 | 1411 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2005 | 11965 | 0.090 |
Why?
|
| Acetylcysteine | 2 | 2017 | 143 | 0.080 |
Why?
|
| Thinness | 1 | 2008 | 82 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 239 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2017 | 2588 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2002 | 803 | 0.070 |
Why?
|
| Adiposity | 1 | 2008 | 237 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2005 | 869 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2005 | 246 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 1037 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4314 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 4233 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 5 | 2005 | 99 | 0.070 |
Why?
|
| Receptors, Notch | 4 | 2002 | 383 | 0.070 |
Why?
|
| Systole | 1 | 2005 | 196 | 0.070 |
Why?
|
| Receptor, Notch1 | 3 | 2002 | 218 | 0.060 |
Why?
|
| Adult | 7 | 2018 | 77950 | 0.060 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 33 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 769 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 6089 | 0.050 |
Why?
|
| DNA Adducts | 1 | 2003 | 210 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2001 | 292 | 0.050 |
Why?
|
| Longevity | 1 | 2003 | 154 | 0.050 |
Why?
|
| Mice, Knockout | 7 | 2008 | 5710 | 0.050 |
Why?
|
| Social Behavior | 1 | 2023 | 306 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 682 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 358 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 21445 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 12873 | 0.050 |
Why?
|
| Lens, Crystalline | 1 | 2001 | 155 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 45 | 0.050 |
Why?
|
| Male | 8 | 2018 | 123000 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 132 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2000 | 6150 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 875 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2000 | 137 | 0.040 |
Why?
|
| Cataract | 1 | 2001 | 218 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 264 | 0.040 |
Why?
|
| Hybrid Cells | 1 | 1999 | 128 | 0.040 |
Why?
|
| Exons | 1 | 2003 | 1328 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2000 | 311 | 0.040 |
Why?
|
| Calcium | 1 | 2005 | 1537 | 0.040 |
Why?
|
| Myocardium | 1 | 2005 | 1313 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 1998 | 101 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 44 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 1999 | 256 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 10 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2018 | 935 | 0.040 |
Why?
|
| Breath Holding | 1 | 2018 | 44 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 634 | 0.040 |
Why?
|
| Transfection | 4 | 2005 | 2944 | 0.040 |
Why?
|
| Cytosol | 1 | 1998 | 238 | 0.040 |
Why?
|
| Somites | 1 | 1997 | 24 | 0.040 |
Why?
|
| Cell Line | 5 | 2005 | 5114 | 0.040 |
Why?
|
| Nervous System | 1 | 1998 | 165 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 294 | 0.040 |
Why?
|
| Middle Aged | 4 | 2018 | 86204 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 1998 | 229 | 0.040 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 45 | 0.040 |
Why?
|
| Pentoxifylline | 1 | 2017 | 35 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 80 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2017 | 18 | 0.040 |
Why?
|
| Bed Rest | 1 | 2017 | 23 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 237 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 6942 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2017 | 28 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 135 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 1555 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 997 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 1073 | 0.040 |
Why?
|
| Melanocytes | 1 | 1997 | 219 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1997 | 217 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1998 | 844 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 120 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 1265 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 151 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2005 | 850 | 0.030 |
Why?
|
| Obesity | 1 | 2008 | 2884 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 240 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 257 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1471 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 31252 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 323 | 0.030 |
Why?
|
| Behavioral Research | 1 | 2014 | 23 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 5539 | 0.030 |
Why?
|
| Base Sequence | 1 | 2001 | 4917 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 889 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2006 | 591 | 0.030 |
Why?
|
| Blastocyst | 2 | 2005 | 124 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1559 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 521 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2232 | 0.030 |
Why?
|
| Metformin | 1 | 2017 | 378 | 0.030 |
Why?
|
| Female | 5 | 2018 | 141928 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 2488 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 586 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 2022 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 907 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 1863 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 5395 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 1375 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 3343 | 0.020 |
Why?
|
| United States | 2 | 2020 | 15433 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2005 | 5637 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 70117 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 764 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 3552 | 0.020 |
Why?
|
| Neurons | 3 | 2005 | 2287 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 849 | 0.020 |
Why?
|
| Gene Expression | 1 | 1997 | 3570 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 769 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 5159 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 3536 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 1487 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 7702 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 339 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2006 | 176 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 27 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 22 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 38 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 60 | 0.020 |
Why?
|
| Carbamates | 1 | 2005 | 77 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 4938 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 6295 | 0.020 |
Why?
|
| DNA | 2 | 2005 | 2693 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 3639 | 0.020 |
Why?
|
| Dipeptides | 1 | 2005 | 91 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2005 | 148 | 0.020 |
Why?
|
| Protein Binding | 2 | 2002 | 3438 | 0.020 |
Why?
|
| Time Factors | 3 | 2005 | 12926 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2005 | 191 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 585 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 2003 | 855 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 291 | 0.020 |
Why?
|
| Affinity Labels | 1 | 2003 | 28 | 0.010 |
Why?
|
| Breeding | 1 | 2003 | 29 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 244 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 545 | 0.010 |
Why?
|
| Mutation | 4 | 2005 | 15179 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 7548 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 153 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 126 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 394 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 34 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 2049 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 43 | 0.010 |
Why?
|
| Leupeptins | 1 | 2002 | 68 | 0.010 |
Why?
|
| Fluorometry | 1 | 2002 | 34 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 62 | 0.010 |
Why?
|
| Osmosis | 1 | 2001 | 18 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 139 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 43 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 208 | 0.010 |
Why?
|
| Aquaporins | 1 | 2001 | 23 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 793 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2003 | 242 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 549 | 0.010 |
Why?
|
| Solubility | 1 | 2002 | 242 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 329 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 241 | 0.010 |
Why?
|
| Chimera | 1 | 2001 | 145 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 167 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 15694 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 332 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 568 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 2171 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 2000 | 25 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1998 | 5061 | 0.010 |
Why?
|
| Lasers | 1 | 2001 | 198 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2000 | 70 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 1213 | 0.010 |
Why?
|
| Genes, BRCA2 | 1 | 2003 | 309 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 210 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 146 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 445 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 846 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2001 | 269 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 4109 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 2283 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 870 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 281 | 0.010 |
Why?
|
| Water | 1 | 2001 | 361 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 2437 | 0.010 |
Why?
|
| Homozygote | 1 | 2001 | 717 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2002 | 436 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 308 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 995 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 741 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 507 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 1020 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 6009 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 2489 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 3045 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 3254 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 1620 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 2084 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 1879 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 1682 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 7222 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 1442 | 0.010 |
Why?
|
| DNA Damage | 1 | 2003 | 1954 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 3101 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2000 | 1271 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 2450 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 3154 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 7226 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 4143 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 2086 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 5377 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 4078 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 6682 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 4821 | 0.010 |
Why?
|
| Apoptosis | 1 | 2002 | 7591 | 0.000 |
Why?
|